— T-Mobile US Inc. (NASDAQ: TMUS) reported its third-quarter 2019 earnings of $1.01 per share versus $0.96 per share expected.
— Total revenues rose by 2% to $11.1 billion versus $11.33 billion expected. The results were driven by growth in service revenues partially offset by a decline in equipment revenues primarily due to a decrease in the number of devices sold.
— Total net customer additions increased by 7% to 1.75 million. Total customers at the end of the period increased by 9% to 84.18 million.
— Branded postpaid net additions declined by 0.5% to 1.07 million. Branded postpaid net additions fell by 3% to 754,000. Branded postpaid phone churn fell to 0.89% from 1.02% a year ago.
— Branded prepaid net additions jumped by 77% to 62,000. Branded prepaid churn dropped to 3.98% from 4.12% a year earlier.
— For 2019, the company lifted postpaid net customer additions outlook to the range of 4.1 to 4.3 million from the previous estimates range of 3.5 to 4 million.
— Adjusted EBITDA is now expected to be in the range of $13.1 billion to $13.3 billion, up from the previous forecast range of $12.9 billion to $13.3 billion in 2019.
Read: AT&T Q3 earnings review
— In Q4 2019, pre-close merger-related costs are expected to be $125 million to $150 million before taxes.
— T-Mobile will launch its nationwide 5G network in 2019 in conjunction with the introduction of the first compatible 5G smartphones, including OnePlus 7T Pro 5G McLaren.
— At the end of Q3, T-Mobile owned a nationwide average of 31 MHz of 600 MHz low band spectrum. As of September 30, 2019, the company had cleared 231 million POPs and expects to clear spectrum covering about 275 million POPs by year-end.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key